Miraculins develops new assay in preeclampsia program
May 17, 2010 by stephenkilmer · Leave a Comment
Miraculins (TSX-V:MOM) has developed an ultrasensitive assay for the detection of soluble endoglin, optimized for serum and urine, in an ELISA format as part of its preeclampsia program. Endoglin is the lead biomarker in its preeclampsia portfolio. “Our initial focus will be to offer this assay to investigators as a research-use-only kit to support preeclampsia [...]
Listen to BioTuesdays 
